Alvaro Rodriguez, MD;
Francisco J. Rodriguez, MD;
Ricardo Infante, MD;
Silvia Florez, MD;
David Medina, MD
(Bogota, Colombia) |
Photodynamic Therapy in Conditions Other than Age Related Macular Degeneration
Volume 34, Number # 1, 2006 Series
Alvaro Rodriguez, MD;
Francisco J. Rodriguez, MD;
Ricardo Infante, MD;
Silvia Florez, MD;
David Medina, MD
(Bogota, Colombia) |
1. Congdon N, O�Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85.
2. Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 111:1200-1209, 1993.
3. Treatment of Age Related Macular Degenerations with Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin. One year results of 2 randomized clinical trials. TAP Report 1. Arch. Ophthalmol. 117:1329-1345, 1999.
4. Verteporfin in photodynamic therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with Verteporfin: 1 year results of a randomized clinical trial � VIP Report 1. Ophthalmology 108:841 � 852, 2001.
5. Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr; Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology. 2004 Sep;111(9):1725-33.
6. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for Neovascular Age-Related Macular Degeneration. N Engl J Med 2004; 351: 2805-16.
7. Michels S, Michels R, Simader C, Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a longterm follow-up. Retina 2005; 25: 697-703.
|
